Growth Metrics

Gilead Sciences (GILD) Cash from Operations (2016 - 2025)

Gilead Sciences' Cash from Operations history spans 17 years, with the latest figure at 3327000000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 11.83% year-over-year to 3327000000.0; the TTM value through Dec 2025 reached 10019000000.0, down 7.47%, while the annual FY2025 figure was 10019000000.0, 7.47% down from the prior year.
  • Cash from Operations reached 3327000000.0 in Q4 2025 per GILD's latest filing, down from 4108000000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 4309000000.0 in Q3 2024 to a low of 827000000.0 in Q2 2025.
  • Average Cash from Operations over 5 years is 2465450000.0, with a median of 2327000000.0 recorded in 2021.
  • The largest YoY upside for Cash from Operations was 145.53% in 2024 against a maximum downside of 43.33% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 3205000000.0 in 2021, then decreased by 19.91% to 2567000000.0 in 2022, then fell by 15.5% to 2169000000.0 in 2023, then skyrocketed by 37.16% to 2975000000.0 in 2024, then grew by 11.83% to 3327000000.0 in 2025.
  • Per Business Quant, the three most recent readings for GILD's Cash from Operations are 3327000000.0 (Q4 2025), 4108000000.0 (Q3 2025), and 827000000.0 (Q2 2025).